Last reviewed · How we verify

NCT04836078

Role of Simvastatin Microsponges in Treatment of Periodontitis

Completed EARLY_PHASE1 Last updated 8 April 2021
What this trial tests

EARLY_PHASE1 trial testing open flap subgingival debridement in Periodontitis in 24 participants. Completed in 10 October 2020.

Timeline
10 February 2020
Primary endpoint
10 August 2020
10 October 2020

Quick facts

Lead sponsorAssiut University
PhaseEARLY_PHASE1
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment24
Start date10 February 2020
Primary completion10 August 2020
Estimated completion10 October 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 30 to 50, any sex, with Periodontitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the aim of our study is to enhance the dissolution and subsequently the local penetration of the drug through the sulcus in addition to controlling the drug release so that, the drug could be potentially absorbed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Periodontitis

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04836078.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing